Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

WCLC 2022 | Checkpoint inhibitors for lung cancer treatment

Mirjana Rajer, MD, PhD, Institute of Oncology Ljubljana, Ljubljana, Slovenia, talks on the introduction of checkpoint inhibitors into treatment landscape of lung cancer, and managing their associated toxicities. This interview took place at the IASLC 2022 World Conference on Lung Cancer congress in Vienna, Austria.